Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

Health Secretary Robert F. Kennedy Jr. called the treatment 'a powerful glimpse into the future of personalized medicine' ...

A West Coast biotech entrepreneur says he’s secured $30 million to form a public-benefit company to study how to safely create genetically edited babies, marking the largest known investment into the ...

RheumaGen, Inc., a cell and gene therapy company engineering a new class of therapeutics to cure common autoimmune diseases, today announced groundbreaking preclinical research that supports a nearly ...

Most current approaches rely on adding nuclear localization signal (NLS) motifs to the ends of Cas9 to facilitate nuclear entry. However, this method is inefficient, and much of the Cas9 that is ...

We are now in the second great wave of the genetic revolution, not defined by reading the human code of life, but by rewriting it.

Cathy Tie, who launched her first biotech in SF's IndieBio, now leads Manhattan Genomics in controversial push to edit human ...

Samsung Group said Thursday it will invest in Arbor Biotechnologies, a US-based gene editing company, through its Life ...

Samsung is proceeding with an investment in U.S.-based Arbor Biotechnologies (Arbor Bio), a company specializing in ...